The Wegovy pill saw the fastest take-up in weight-loss drug history. Novo Nordisk only narrowly lifted guidance.

Novo Nordisk on Wednesday narrowly improved its financial guidance for a year where it still sees profit and sales falling after the fastest take-up in weight-loss drug history for its Wegovy pill.